ArticleBlood cancer journal2018
Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia.
Open access · goldAbstract readLetter
In one paragraph
Article in Blood cancer journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Loss of the RAD-51 isoform A redirects DNA repair and preserves genome stability in FANCD2-deficient Caenorhabditis elegans.BMC biology · 2026Article
- Fancl-mutant mice reveal central role of monoubiquitination in Fanconi anemia and a model for therapeutic gene editing.Blood advances · 2026Article
- First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants.International journal of hematology · 2024Article
- Fanconi anemia-associated chromosomal radial formation is dependent on POLθ-mediated alternative end joining.Cell reports · 2023Article
- Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Nature communications · 2022Article
- A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.Genome medicine · 2021Article
- Chitosan as possible inhibitory agents and delivery systems in leukemia.Cancer cell international · 2021Review
- Canonical and Noncanonical Roles of Fanconi Anemia Proteins: Implications in Cancer Predisposition.Cancers · 2020Review
- Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes.International journal of molecular sciences · 2020Review
- In vivo analysis of FANCD2 recruitment at meiotic DNA breaks in Caenorhabditis elegans.Scientific reports · 2020Article
- NovelMolecular cytogenetics · 2020Article
- DNA- and DNA-Protein-Crosslink Repair in Plants.International journal of molecular sciences · 2019Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors at 9 institutions in 2 countries.
Kyaw Ze Ya MaungBasil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville, SA, Australia.
Paul J LeoInstitute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology and University of Queensland Diamantina Institute, Brisbane, QLD, Australia.
Mahmoud BassalCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
Debora A CasolariSchool of Medicine, University of Adelaide, Adelaide, SA, Australia.
James X GrayBasil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville, SA, Australia.
Sarah C BraySchool of Medicine, University of Adelaide, Adelaide, SA, Australia.
Stephen PedersonAdelaide Bioinformatics, School of Biological Sciences and School of Mathematics, University Of Adelaide, Adelaide, SA, Australia.
Deepak SinghalSchool of Medicine, University of Adelaide, Adelaide, SA, Australia.
Saumya E SamaraweeraCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
Tran NguyenCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
Gökhan CildirCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
Mhairi MarshallInstitute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology and University of Queensland Diamantina Institute, Brisbane, QLD, Australia.
Adam EwingMater Research Institute, University of Queensland, Brisbane, QLD, Australia.
Emma L DuncanInstitute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology and University of Queensland Diamantina Institute, Brisbane, QLD, Australia.
Matthew A BrownInstitute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology and University of Queensland Diamantina Institute, Brisbane, QLD, Australia.
Russell SaalInstitute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology and University of Queensland Diamantina Institute, Brisbane, QLD, Australia.
Vinay TergaonkarCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
Luen Bik ToSchool of Medicine, University of Adelaide, Adelaide, SA, Australia.
Paula MarltonClinical Haematology, Princess Alexandra Hospital Brisbane, Woolloongabba, QLD, Australia.
Devinder GillClinical Haematology, Princess Alexandra Hospital Brisbane, Woolloongabba, QLD, Australia.
Ian LewisSchool of Medicine, University of Adelaide, Adelaide, SA, Australia.
Andrew J DeansSt Vincent's Institute of Medical Research, Melbourne, VIC, Australia.
Anna L BrownCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
Richard J D'AndreaSchool of Medicine, University of Adelaide, Adelaide, SA, Australia. richard.dandrea@unisa.edu.au.
Thomas J GondaUniversity of South Australia Cancer Research Institute, Adelaide, SA, Australia. Thomas.Gonda@unisa.edu.au.ORCID http://orcid.org/0000-0002-8792-3021
South Australia Pathology · AUTranslational Research Institute · AUPrincess Alexandra Hospital · AUBasil Hetzel Institute · AUBond University · AURoyal Adelaide Hospital · AUSt Vincents Institute of Medical Research · AUThe University of Adelaide · AUThe University of Queensland · AU
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Genetic Association StudiesGenetic Predisposition to DiseaseGenetic VariationAllelesFanconi Anemia Complementation Group ProteinsGenotypeHumansLeukemia, Myeloid, AcuteMutationFanconi Anemia Complementation Group Proteins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.